ArticleEndoscopic ultrasound
Evaluation of endoscopic resectability for ampullary tumors by EUS and side-viewing duodenoscopy.
Article in Endoscopic ultrasound. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: Accurate preoperative assessment of ampullary tumors is vital in planning an appropriate endoscopic papillectomy strategy. The use of EUS and side-viewing duodenoscopy (SVD) with narrow band imaging (NBI) varies across studies. Reports on critical features under EUS and SVD + NBI are lacking. We aimed to demonstrate (1) the theoretical and real-world management of ampullary lesions, (2) the implementation of preresection biopsy or fine needle aspiration (FNA), and (3) critical features under EUS and SVD + NBI for preoperative assessment. Methods: Data from consecutive patients with suspected papillary lesions referred for EUS and SVD + NBI from January 2020 to December 2023 were retrospectively analyzed. The primary outcomes were the difference between theory and reality for management for ampullary nontumor-adenoma-adenocarcinoma, and the high-risk features under EUS and SVD + NBI for adenocarcinoma, T1 stage and ductal invasion. The secondary outcomes were the value of preoperative biopsy and FNA. Results: A total of 121 patients with suspected ampullary tumors were included in the analysis. Less than half (27.40%) of the patients in the surgery group could have been classified as endoscopically resectable. A total of 46.4% and 35% of the biopsy and FNA pathological results, respectively, were inconsistent with the postoperative results. Protrusion with atypical ulcers, NBI type III, EUS size ≥3.0 cm, hypoechoicity, poor blood supply, and EUS ductal invasion were high-risk factors for adenocarcinoma. A size ≥3.0 cm and hypoechoic status were high-risk factors for T1 and ductal invasion. The cutoff value of the stain ratio for adenocarcinoma was 5.35, with a sensitivity, specificity, and accuracy of 88.5%, 93.0%, and 90.8%, respectively. Conclusions: Preoperative assessment of ampullary tumors is necessary, but biopsy and FNA are not sufficient. EUS and SVD + NBI, which focus on essential features, are valuable for evaluating ampullary tumors for endoscopic resectability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.